CONMED (CNMD) stock
Members see every stock ranked and every check behind each score, live.
Why CNMD scores 5
Below AverageTransition, 4 of 14 checks firingWhat the Quality Score means
- +4Chart checks 4 of 14 firing right now, one point each
- +1Profit Made $47.1M in the year to Dec 31, 2025, down 64% from $132M the year before, from the SEC filing
What's next
Reports Wed Oct 28, after the close
After its last 4 reports it closed +1.6% on average, higher 2 of 4 times.
What would turn CNMD's score around: 5 things, for members
Here is what members see.
Every stock gets a card like this one, and a page with its price in real time, every line of its score, the chart, and its filings.





CNMD has 4 of 14 checks firing
One per group is shown here.
Also on the chart
- RSI 1444.9
- MACD (12, 26, 9)Below signal
- 50-day average$47.81
- 200-day average$40.88
- ADX 1418.5
- Support$44.39
- Resistance$47.08
- Bollinger Bands (20, 2)Inside
- Volume0.7x
How CNMD ranks in Medical Devices
CNMD is #27 of 75 by Quality Score. The top three are shown with their scores, and more by name.
DXCM4/1415
BLFS3/1415
HTFL6/1414
CBLLOpen for its score
CDREOpen for its score
COOOpen for its score
DCTHOpen for its score
CNMD4/145
When does CNMD report earnings, and what happens after?
Reports Wed Oct 28, after the close (in 27 days). The company has set the date.
| Reported | When | Gap | Reaction | 5 sessions |
|---|---|---|---|---|
| Jul 29, 2026After close | After close | +9.9% | +8.7% | +14.1% |
| Apr 29, 2026After close | After close | +3.0% | +1.9% | +3.8% |
| Jan 28, 2026After close | After close | +0.2% | -3.6% | +3.2% |
| Nov 5, 2025After close | After close | -3.2% | -0.5% | -2.0% |
Who is trading CNMD
CNMD trades by Congress and the White House
2 trades disclosed in the last six months. The newest:
About CONMED
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
Every line of the score, on every stock.
- Real-time prices, no delay
- Every line of CNMD's score, with the points and the reason
- All 14 checks on CNMD and on all 2,958 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on CNMD
Straight answers.
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Members, trial included, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.
Do I need an account?
Not for the first 24 hours. Tap any green button and you're in, with no email and no password. To keep going, create your account with Google, Apple, or your email. There is no password to make up.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.